You know that newsletter pitchmen can't resist coronavirus-related stories, and I imagine those spiels touting various technology, biotech and vaccine companies will probably continue as long as COVID-19 is on every front page -- the one I've been asked about most in the past few days is from Nick Hodge, who says his stock could go from $1 to $20 because it has the first machine that can test for the virus on site... so what's he talking about? Just click below to.... |